The CGG Repeat Expansion in RILPL1 is Associated with Oculopharyngodistal Myopathy Type 4.

Jiaxi Yu,Jingli Shan,Meng Yu,Li Di,Zhiying Xie,Wei Zhang,He Lv,Lingchao Meng,Yiming Zheng,Yawen Zhao,Qiang Gang,Xueyu Guo,Yang Wang,Jianying Xi,Wenhua Zhu,Yuwei Da,Daojun Hong,Yun Yuan,Chuanzhu Yan,Zhaoxia Wang,Jianwen Deng

DOI: https://doi.org/10.1016/j.ajhg.2022.01.012

2022-01-01

Abstract:Recent studies indicate that CGG repeat expansions in LRP12, GIPC1, and NOTCH2NLC are associated with oculopharyngodistal myopathy (OPDM) types 1, 2, and 3, respectively. However, some clinicopathologically confirmed OPDM cases continue to have unknown genetic causes. Here, through a combination of long-read whole-genome sequencing (LRS), repeat-primed polymerase chain reaction (RP-PCR), and fluorescence amplicon length analysis PCR (AL-PCR), we found that a CGG repeat expansion in the 5' UTR of RILPL1 is associated with familial and simplex OPDM type 4 (OPDM4). The number of repeats ranged from 139 to 197. Methylation analysis indicates that the methylation levels in RILPL1 were unaltered in OPDM4 individuals. Analyses of muscle biopsies suggested that the expanded CGG repeat might be translated into a toxic poly-glycine protein that co-localizes with p62 in intranuclear inclusions. Moreover, analyses suggest that the toxic RNA gain-of-function effects also contributed to the pathogenesis of this disease. Intriguingly, all four types of OPDM have been found to be associated with the CGG repeat expansions located in 5' UTRs. This finding suggests that a common pathogenic mechanism, driven by the CGG repeat expansion, might underlie all cases of OPDM.